Skip to main content

and
  1. Article

    Open Access

    The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

    The clinical trials using immunotherapy have been performed for the treatment of variety of malignant tumors. However, large-scale meta-analysis of combined DC-CTL/CIK therapy on immune and clinical response i...

    Ying Wang, Zenghui Xu, Fu** Zhou, Yan Sun in Experimental Hematology & Oncology (2015)

  2. No Access

    Article

    Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients

    This phase I clinical trial is designed to assess the safety and feasibility of the epidermal growth factor receptor (EGFR) chimeric antigen receptor (CAR) T-cell generated by the piggyBac transposon system in...

    Yajun Zhang, Zhiwei Zhang, Yongmei Ding in Journal of Cancer Research and Clinical On… (2021)